290 related articles for article (PubMed ID: 26956593)
1. Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy.
Ren Y; Wang R; Gao L; Li K; Zhou X; Guo H; Liu C; Han D; Tian J; Ye Q; Hu YT; Sun D; Yuan X; Zhang N
J Control Release; 2016 Apr; 228():74-86. PubMed ID: 26956593
[TBL] [Abstract][Full Text] [Related]
2. The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy.
Li Y; He D; Tu J; Wang R; Zu C; Chen Y; Yang W; Shi D; Webster TJ; Shen Y
Nanoscale; 2018 May; 10(18):8628-8641. PubMed ID: 29697100
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of a multifunctional gold-doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release.
Khutale GV; Casey A
Eur J Pharm Biopharm; 2017 Oct; 119():372-380. PubMed ID: 28736333
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles modified hollow carbon system for dual-responsive release and chemo-photothermal synergistic therapy of tumor.
Zhao Q; Yang Y; Wang H; Lei W; Liu Y; Wang S
J Colloid Interface Sci; 2019 Oct; 554():239-249. PubMed ID: 31301524
[TBL] [Abstract][Full Text] [Related]
5. Calcium phosphate-polymeric nanoparticle system for co-delivery of microRNA-21 inhibitor and doxorubicin.
Sriram V; Lee JY
Colloids Surf B Biointerfaces; 2021 Dec; 208():112061. PubMed ID: 34492599
[TBL] [Abstract][Full Text] [Related]
6. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma.
Qian X; Long L; Shi Z; Liu C; Qiu M; Sheng J; Pu P; Yuan X; Ren Y; Kang C
Biomaterials; 2014 Feb; 35(7):2322-35. PubMed ID: 24332459
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes.
Zhang S; Han L; Wei J; Shi Z; Pu P; Zhang J; Yuan X; Kang C
Int J Oncol; 2015 Apr; 46(4):1589-600. PubMed ID: 25625875
[TBL] [Abstract][Full Text] [Related]
8. Localized sequence-specific release of a chemopreventive agent and an anticancer drug in a time-controllable manner to enhance therapeutic efficacy.
Pan WY; Lin KJ; Huang CC; Chiang WL; Lin YJ; Lin WC; Chuang EY; Chang Y; Sung HW
Biomaterials; 2016 Sep; 101():241-50. PubMed ID: 27294541
[TBL] [Abstract][Full Text] [Related]
9. A novel platform for high sensitivity determination of PbP2a based on gold nanoparticles composited graphitized mesoporous carbon and doxorubicin loaded hollow gold nanospheres.
Yang J; Shen H; Zhang X; Tao Y; Xiang H; Xie G
Biosens Bioelectron; 2016 Mar; 77():1119-25. PubMed ID: 26569442
[TBL] [Abstract][Full Text] [Related]
10. Gold cluster-labeled thermosensitive liposmes enhance triggered drug release in the tumor microenvironment by a photothermal effect.
Kwon HJ; Byeon Y; Jeon HN; Cho SH; Han HD; Shin BC
J Control Release; 2015 Oct; 216():132-9. PubMed ID: 26247553
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells.
Zhang Z; Xu S; Wang Y; Yu Y; Li F; Zhu H; Shen Y; Huang S; Guo S
J Colloid Interface Sci; 2018 Jan; 509():47-57. PubMed ID: 28881205
[TBL] [Abstract][Full Text] [Related]
12. Lipogels responsive to near-infrared light for the triggered release of therapeutic agents.
Martín-Saavedra F; Ruiz-Hernández E; Escudero-Duch C; Prieto M; Arruebo M; Sadeghi N; Deckers R; Storm G; Hennink WE; Santamaría J; Vilaboa N
Acta Biomater; 2017 Oct; 61():54-65. PubMed ID: 28801266
[TBL] [Abstract][Full Text] [Related]
13. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles.
Zhao N; Wu B; Hu X; Xing D
Biomaterials; 2017 Oct; 141():40-49. PubMed ID: 28666101
[TBL] [Abstract][Full Text] [Related]
14. Gold nanorod-cored biodegradable micelles as a robust and remotely controllable doxorubicin release system for potent inhibition of drug-sensitive and -resistant cancer cells.
Zhong Y; Wang C; Cheng L; Meng F; Zhong Z; Liu Z
Biomacromolecules; 2013 Jul; 14(7):2411-9. PubMed ID: 23701318
[TBL] [Abstract][Full Text] [Related]
15. On-Demand Drug Release from Gold Nanoturf for a Thermo- and Chemotherapeutic Esophageal Stent.
Lee S; Hwang G; Kim TH; Kwon SJ; Kim JU; Koh K; Park B; Hong H; Yu KJ; Chae H; Jung Y; Lee J; Kim TI
ACS Nano; 2018 Jul; 12(7):6756-6766. PubMed ID: 29878749
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
17. One-Pot Fabrication of Hollow Porphyrinic MOF Nanoparticles with Ultrahigh Drug Loading toward Controlled Delivery and Synergistic Cancer Therapy.
Sun X; He G; Xiong C; Wang C; Lian X; Hu L; Li Z; Dalgarno SJ; Yang YW; Tian J
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3679-3693. PubMed ID: 33464038
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-conjugated CuS nanoparticles for efficient synergistic therapy triggered by near-infrared light.
Bi H; Dai Y; Lv R; Zhong C; He F; Gai S; Gulzar A; Yang G; Yang P
Dalton Trans; 2016 Mar; 45(12):5101-10. PubMed ID: 26883928
[TBL] [Abstract][Full Text] [Related]
19. Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy.
Feng Y; Cheng Y; Chang Y; Jian H; Zheng R; Wu X; Xu K; Wang L; Ma X; Li X; Zhang H
Biomaterials; 2019 Oct; 217():119327. PubMed ID: 31299626
[TBL] [Abstract][Full Text] [Related]
20. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy.
Lin L; Fan Y; Gao F; Jin L; Li D; Sun W; Li F; Qin P; Shi Q; Shi X; Du L
Theranostics; 2018; 8(7):1923-1939. PubMed ID: 29556365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
